Systemic lysis protects against the effects of platelet activation during coronary thrombolysis.
Systemic lysis may protect against the platelet activation and ongoing thrombosis associated with coronary thrombolysis. To address this hypothesis, we compared urokinase and tissue-type plasminogen activator (t-PA) given intravenously in a chronic, canine model of coronary thrombosis. T-PA 10 micro...
Kaydedildi:
| Yayımlandı: | J Clin Invest |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Clinical Investigation
1991
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1939647/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115471 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|